Table 3.
The relationship between age and the number of Enterovirus A71 (EV-A71), coxsackievirus A16 (CV-A16), and other serotypes in patients with enterovirus in Kunming children's Hospital from 2014 to 2018.
| Age group (Years/Month) | Years | P-valuea | ||||
|---|---|---|---|---|---|---|
| 2014 | 2015 | 2016 | 2017 | 2018 | ||
| ≤0/6 | 365 (1.83%) | 353 (1.80%) | 262 (1.46%) | 274 (1.81%) | 412 (1.71%) | <.001b |
| 0/6–0/12 | 1573 (7.89%) | 1861 (9.46%) | 955 (5.31%) | 1544 (10.22%) | 1970 (8.17%) | |
| 1/0–2/0 | 5812 (29.14%) | 5872 (29.86%) | 4696 (26.09%) | 4131 (27.36%) | 7484 (31.02%) | |
| 2/0–5/0 | 10,303 (51.65%) | 9976 (50.74%) | 10,241 (56.90%) | 7665 (50.76%) | 11,340 (47.00%) | |
| 5/0–14/0 | 1847 (9.26%) | 1595 (8.11%) | 1835 (10.20%) | 1481 (9.81%) | 2901 (12.02%) | |
| ≥14/0 | 46 (0.23%) | 5 (0.03%) | 8 (0.04%) | 6 (0.04%) | 20 (0.08%) | |
| Total | 19,946 | 19,662 | 17,997 | 15,101 | 24,127 | |
a
Analysis of the difference between the number and age group of EV-A71, CV-A16, and other serotypes in 2014–2018 by chi-square test.
b
Significant statistical differences, P < .001.